Enovis (ENOV) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Enovis · Health Care · ref. ETF XLV · 51 calls · price $18.99
What the company does: Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally.
📈 Enovis (ENOV) stock price
$18.99-38.9% over range
Oct 14, 25low $17.43 · high $32.87Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 8 analysts
📊 JPI status : Enovis has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ENOV price target & analyst consensus — price $18.99
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$47+147.5%
Median target · of 8 targets$35+84.3%
Lowest target · 1 firm of 8$29+52.7%
Current price$18.99
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
8100%
$29 ↔ $47
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy8100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ENOV price target all
All 51 calls, one by one, with our verdict on each firm.
→ See all 51 targets, analyst by analyst💡 The best analysts on ENOV most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ENOV? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Enovis? The JPI assistant answers using our backtest data.
🏛️ Enovis insider buying: who's buying and how much › open the full page
2 insiders bought4 buys / 6 mo $476k👥 Cluster buy
🔎 Detailed analyses
✅ Historical analyst reliability on ENOV
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Baird ↗ | 25% | -9.7% | 4 |
| Canaccord Genuity ↗ | 17% | -12.3% | 6 |
| UBS ↗ | 0% | -17.0% | 2 |
| Wells Fargo ↗ | 0% | -17.2% | 3 |
| Evercore ISI Group ↗ | 0% | -20.4% | 4 |
| Needham ↗ | 0% | -26.0% | 16 |
| JMP Securities | 0% | -26.1% | 2 |
📊 What $1,000 invested in Enovis would be worth › open the full page
In short — $1,000 invested in Enovis 10 years ago would be worth $613 today, i.e. -5%/yr on average. Best year: 2019 (+74%), worst: 2018 (-47%). Price performance, excluding dividends.
If I'd invested $1,000 in Enovis
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $562 | -44% |
| 3 years ago | $461 | -54% |
| 5 years ago | $375 | -63% |
Return by year (Enovis)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -7% | $925 (-7%) |
| 2025 | -39% | $562 (-44%) |
| 2024 | -22% | $440 (-56%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Enovis
Loading news…
📋 All analyst calls on ENOV
Filtered on — · ✕ show all
▲ Buy · 🎯$34
Price at call : $18.25 — upside +86%
Today : $18.99 — upside +79%
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Oct 12, 27
matures : Oct 12, 27
Wells Fargo ↗
Sep 2, 26
▲ Overweight · 🎯$33
Price at call : $19.4 — upside +70%
Today : $18.99 — upside +74%
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
Citizens
Sep 2, 26
▲ Market Outperform · 🎯$47
Price at call : $20.2 — upside +133%
Today : $18.99 — upside +147%
🎯 on ENOV : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
Freedom Capital Markets
Sep 2, 26
▲ Buy · 🎯$36
Price at call : $20.2 — upside +78%
Today : $18.99 — upside +90%
🎯 on ENOV : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
▲ Buy · 🎯$36
Price at call : $20.53 — upside +75%
Today : $18.99 — upside +90%
🎯 on ENOV : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Sep 1, 27
matures : Sep 1, 27
Canaccord Genuity ↗
Aug 17, 26
▲ Buy · 🎯$45
Price at call : $24.74 — upside +82%
Today : $18.99 — upside +137%
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
Wells Fargo ↗
Aug 7, 26
▲ Overweight · 🎯$39
Price at call : $24.24 — upside +61%
Today : $18.99 — upside +105%
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Buy · 🎯$40
Price at call : $26.61 — upside +50%
Today : $18.99 — upside +111%
🎯 on ENOV : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
See the other 43 calls, newest to oldest
BMO Capital ↗
Jul 9, 26
▲ Outperform · 🎯$29
Price at call : $25.22 — upside +15%
Today : $18.99 — upside +53%
🎯 on ENOV : no call matured yet · 📊 on Health : 43.3% · -2.2% (67 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$32
Price at call : $25.52 — upside +25%
Today : $18.99 — upside +69%
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Buy · 🎯$39
Price at call : $24.19 — upside +61%
Today : $18.99 — upside +105%
🎯 on ENOV : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
Evercore ISI Group ↗
May 8, 26
▲ Outperform · 🎯$36
Price at call : $24.78 — upside +45%
Today : $18.99 — upside +90%
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Wells Fargo ↗
May 8, 26
▲ Overweight · 🎯$40
Price at call : $26.52 — upside +51%
Today : $18.99 — upside +111%
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$35
Price at call : $22.52 — upside +55%
Today : $18.99 — upside +84%
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Buy · 🎯$43
Price at call : $25.47 — upside +69%
Today : $18.99 — upside +126%
🎯 on ENOV : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$52
Price at call : $25.42 — upside +105%
Today : $18.99 — upside +174%
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Buy · 🎯$41
Price at call : $27.92 — upside +47%
Today : $18.99 — upside +116%
🎯 on ENOV : no call matured yet · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
Canaccord Genuity ↗
Dec 17, 25
▲ Buy · 🎯$50
Price at call : $27.32 — upside +83%
Today : $18.99 — upside +163%
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Freedom Capital Markets
Dec 17, 25
▲ Buy · 🎯$45
Price at call : $27.36 — upside +64%
Today : $18.99 — upside +137%
🎯 on ENOV : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Wells Fargo ↗
Nov 7, 25
▲ Overweight · 🎯$42
Price at call : $30.26 — upside +39%
Today : $18.99 — upside +121%
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Canaccord Genuity ↗
Aug 8, 25
▲ Buy · 🎯$58
Price at call : $28.11 — upside +106%
Today : $18.99 — upside +205%
Expected +106% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-13.8%
stock -14% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$57
Price at call : $28.11 — upside +103%
Today : $18.99 — upside +200%
Expected +103% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
-13.8%
stock -14% · XLV +29%
matured Aug 8, 26
Wells Fargo ↗
Aug 8, 25
▲ Overweight · 🎯$41
Price at call : $28.11 — upside +46%
Today : $18.99 — upside +116%
Expected +46% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-13.8%
stock -14% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$49
Price at call : $28.52 — upside +72%
Today : $18.99 — upside +158%
Expected +72% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-6.7%
stock -7% · XLV +28%
matured Aug 7, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$46
Price at call : $34.74 — upside +32%
Today : $18.99 — upside +142%
Expected +32% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
-32.0%
stock -32% · XLV +20%
matured Jul 8, 26
Canaccord Genuity ↗
May 14, 25
▲ Buy · 🎯$70
Price at call : $35.73 — upside +96%
Today : $18.99 — upside +269%
Expected +96% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-32.0%
stock -32% · XLV +11%
matured May 14, 26
JMP Securities
May 9, 25
▲ Market Outperform · 🎯$55
Price at call : $36.57 — upside +50%
Today : $18.99 — upside +190%
Expected +50% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 unranked overall
-32.2%
stock -32% · XLV +5%
matured May 9, 26
▲ Buy · 🎯$57
Price at call : $33.05 — upside +72%
Today : $18.99 — upside +200%
Expected +72% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-25.0%
stock -25% · XLV +8%
matured May 9, 26
▲ Buy · 🎯$64
Price at call : $34.22 — upside +87%
Today : $18.99 — upside +237%
Expected +87% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-29.9%
stock -30% · XLV +8%
matured Apr 9, 26
▲ Buy · 🎯$64
Price at call : $33.79 — upside +89%
Today : $18.99 — upside +237%
Expected +89% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-32.6%
stock -33% · XLV +2%
matured Apr 2, 26
▲ Buy · 🎯$64
Price at call : $38.12 — upside +68%
Today : $18.99 — upside +237%
Expected +68% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-33.2%
stock -33% · XLV +9%
matured Feb 27, 26
▲ Buy · 🎯$65
Price at call : $47.86 — upside +36%
Today : $18.99 — upside +242%
Expected +36% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-41.4%
stock -41% · XLV -2%
matured Nov 7, 25
JMP Securities
Oct 3, 24
▲ Market Outperform · 🎯$62
Price at call : $39.96 — upside +55%
Today : $18.99 — upside +226%
Expected +55% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 unranked overall
-19.9%
stock -20% · XLV -4%
matured Oct 3, 25
Evercore ISI Group ↗
Oct 1, 24
▲ Outperform · 🎯$58
Price at call : $40.84 — upside +42%
Today : $18.99 — upside +205%
Expected +42% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
-25.2%
stock -25% · XLV -6%
matured Oct 1, 25
■ Neutral neutral · not a buy · 🎯$50
Price at call : $43.4 — gap to target +15%
Today : $18.99 — gap to target +163%
🎯 on ENOV : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Aug 8, 25
matures : Aug 8, 25
▲ Buy · 🎯$65
Price at call : $43.56 — upside +49%
Today : $18.99 — upside +242%
Expected +49% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-34.7%
stock -35% · XLV -13%
matured Aug 8, 25
Evercore ISI Group ↗
Jul 2, 24
▲ Outperform · 🎯$62
Price at call : $44.44 — upside +40%
Today : $18.99 — upside +226%
Expected +40% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (3 calls matureds) · 📊 on Health : 36.4% · -8.5% (33 calls)
-24.3%
stock -24% · XLV -5%
matured Jul 2, 25
■ Neutral neutral · not a buy · 🎯$53
Price at call : $44.84 — gap to target +18%
Today : $18.99 — gap to target +179%
🎯 on ENOV : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Jun 13, 25
matures : Jun 13, 25
▲ Buy · 🎯$82
Price at call : $51.27 — upside +60%
Today : $18.99 — upside +332%
Expected +60% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-33.4%
stock -33% · XLV -2%
matured May 3, 25
▲ Buy · 🎯$82
Price at call : $59.95 — upside +37%
Today : $18.99 — upside +332%
Expected +37% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-46.5%
stock -46% · XLV -5%
matured Apr 10, 25
Wells Fargo ↗
Feb 23, 24
▲ Overweight · 🎯$79
Price at call : $61.56 — upside +28%
Today : $18.99 — upside +316%
Expected +28% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-29.3%
stock -29% · XLV +0%
matured Feb 22, 25
Canaccord Genuity ↗
Feb 23, 24
▲ Buy · 🎯$75
Price at call : $61.56 — upside +22%
Today : $18.99 — upside +295%
Expected +22% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-29.3%
stock -29% · XLV +0%
matured Feb 22, 25
▲ Buy · 🎯$82
Price at call : $62.85 — upside +30%
Today : $18.99 — upside +332%
Expected +30% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-30.7%
stock -31% · XLV -0%
matured Feb 22, 25
Stephens & Co. ↗
Feb 13, 24
▲ Overweight · 🎯$72
Price at call : $59.76 — upside +20%
Today : $18.99 — upside +279%
Expected +20% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (1 call matured) · 📊 on Health : 44.3% · +2.1% (88 calls)
-26.6%
stock -27% · XLV +2%
matured Feb 12, 25
▲ Buy · 🎯$75
Price at call : $60.21 — upside +25%
Today : $18.99 — upside +295%
Expected +25% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (2 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
-20.3%
stock -20% · XLV +2%
matured Jan 21, 25
▲ Buy · 🎯$73
Price at call : $57.33 — upside +27%
Today : $18.99 — upside +284%
Expected +27% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-21.9%
stock -22% · XLV -0%
matured Jan 7, 25
William Blair ↗
Jan 3, 24
▲ Outperform
Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
-22.0%
stock -22% · XLV -0%
matured Jan 2, 25
Canaccord Genuity ↗
Dec 20, 23
▲ Buy · 🎯$71
Price at call : $54.96 — upside +29%
Today : $18.99 — upside +274%
Expected +29% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (4 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-22.7%
stock -23% · XLV +3%
matured Dec 19, 24
▲ Buy · 🎯$70
Price at call : $53.62 — upside +31%
Today : $18.99 — upside +269%
Expected +31% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-14.6%
stock -15% · XLV +4%
matured Dec 14, 24
▲ Buy · 🎯$62
Price at call : $48.22 — upside +29%
Today : $18.99 — upside +226%
Expected +29% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on ENOV : 0% (13 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-0.8%
stock -1% · XLV +16%
matured Nov 7, 24
Argus Research ↗
Jun 28, 22
■ Hold neutral · not a buy
🎯 on ENOV : no call matured yet · 📊 on Health : 18.2% · -27.9% (11 calls)
in progress (365j)
matures : Jun 28, 23
matures : Jun 28, 23
Frequently asked questions
Should I buy Enovis stock?
This isn't buy advice. For Enovis, the analyst consensus is "Buy", with an average price target of $35.00 (+84% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 25% of the time (4 calls tracked on Enovis). We show the numbers — you decide.
Is it too late to buy Enovis? How high can it go?
The most bullish analyst target on Enovis is $47.00 (+147% above today's price); the average is $35.00. That's the upside they see. Check how reliable those analysts have actually been on Enovis on our site before trusting it.
Is Enovis still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 7 analysts have a real record on Enovis, the best hitting 25% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Will Enovis stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will ENOV stock recover (go back up)?
Should you invest in Enovis? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ENOV (and why hesitate).
What has Enovis's past performance been?
Historical returns and a "how much if I had invested" calculator: ENOV performance & returns.
Are insiders buying ENOV stock?
Executives' and large holders' buys and sells, decoded: insider buying on ENOV.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX